Koyfin Home > Directory > Health Care > Akebia Therapeutics > Return on Equity %

Akebia Therapeutics Return on Equity % Chart (AKBA)

Akebia Therapeutics annual/quarterly Return on Equity % from 2013 to 2020.
  • Akebia Therapeutics Return on Equity % for the quarter ending June 06, 2020 was -183.40 a 75.87% decrease of -139.16 year over year
  • Akebia Therapeutics Return on Equity % for the last 12 months ending June 06, 2020 was -86.68 a 7.26% decrease of -6.29 year over year
  • Akebia Therapeutics Annual Return on Equity % for 2019 was -54.27 a 30.23% decrease of -16.41 from 2018
  • Akebia Therapeutics Annual Return on Equity % for 2018 was -37.86 a -104.08% increase of 39.41 from 2017
  • Akebia Therapeutics Annual Return on Equity % for 2017 was -77.27 a -76.47% increase of 59.08 from 2016
Other Margins & Efficiency Metrics:
  • Akebia Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-142m a 62.80% decrease of -89m year over year
  • Akebia Therapeutics Return on Capital % for the quarter ending December 12, 2018 was -149.67 a 74.14% decrease of -110.96 year over year
View Chart On Koyfin

Quarterly AKBA Return on Equity % Data

06/2020-183.40
03/2020-61.43
12/2019-87.65
09/2019-44.25
06/2019-42.86
03/2019-48.19
12/2018-61.71
09/2018-67.55
06/2018-75.08
03/2018-58.61

Annual AKBA Return on Equity % Data

2019-54.27
2018-37.86
2017-77.27
2016-136.35
2015-51.66
2014-54.93
2013-81.71
2012-238.64